SANTA BARBARA, Calif.--(BUSINESS WIRE)--Naryx Pharma, Inc., a leader in the development of new therapies for patients with chronic sinusitis, announced today that Alan B. Colowick, M.D., M.P.H., has been elected to its Board of Directors.
SANTA BARBARA, Calif.--(BUSINESS WIRE)--Naryx Pharma, Inc., a leader in the development of new therapies for patients with chronic sinusitis, announced today that Alan B. Colowick, M.D., M.P.H., has been elected to its Board of Directors.
